Pacific Shuanglin Bio-pharmacy Co (SZSE:000403) ROCE % : 7.35% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Pacific Shuanglin Bio-pharmacy Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pacific Shuanglin Bio-pharmacy Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.35%.

Pacific Shuanglin Bio-pharmacy Co ROCE % Historical Data

The historical data trend for Pacific Shuanglin Bio-pharmacy Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Shuanglin Bio-pharmacy Co ROCE % Chart

Pacific Shuanglin Bio-pharmacy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

28.41

25.35

12.51

9.97

9.46

Pacific Shuanglin Bio-pharmacy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															3.70	5.47	11.70	16.96	7.35

Pacific Shuanglin Bio-pharmacy Co ROCE % Calculation

Pacific Shuanglin Bio-pharmacy Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	696.514	/	( ( (7982.324 - 959.309)	+	(8630.474 - 922.195) )	/ 2 )
	=	696.514	/	( (7023.015	+	7708.279)	/ 2 )
	=	696.514	/	7365.647
	=	9.46 %

Pacific Shuanglin Bio-pharmacy Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	571.832	/	( ( (8630.474 - 922.195)	+	(8717.807 - 859.095) )	/ 2 )
	=	571.832	/	( ( 7708.279	+	7858.712 )	/ 2 )
	=	571.832	/	7783.4955
	=	7.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Pacific Shuanglin Bio-pharmacy Co (SZSE:000403) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pacific Shuanglin Bio-pharmacy Co ROCE % Related Terms

Thank you for viewing the detailed overview of Pacific Shuanglin Bio-pharmacy Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Shuanglin Bio-pharmacy Co (SZSE:000403) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pacific Shuanglin Bio-pharmacy Co Ltd (SZSE:000403) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

8 Changxing South Street, Room 3004, Sunshine City Global Financial Center, Jinyuan District, Shanxi Province, Taiyuan, CHN, 030000

Website

http://www.999yichun.cn

Pacific Shuanglin Bio-pharmacy Co Ltd is engaged in the research, development, production, and marketing of blood products.

Pacific Shuanglin Bio-pharmacy Co (SZSE:000403) Headlines

No Headlines